# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sir John Franklin (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX005-SYN-TD
- Date: 1845-02-24
- Fictional facility: St. Posthumous Health Center
- Fictional author: Cordelia Ashby-Nwankwo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Four-week review after starting amlodipine, two weeks after influenza. **S**

## History of present illness

Sir John has taken amlodipine 5 mg every morning for four weeks. Two weeks ago he had influenza A, treated with five days of oseltamivir; the fever settled in three days, and he is left with a dry cough on cold mornings and tires earlier than usual on his walks, though he is walking two to three miles again. His home readings for the past week average 134/84. He has no ankle swelling, dizziness or flushing. He has lost 1.8 kg since intake. He had his echocardiogram this morning and brought a urine sample. His exercise treadmill test, booked for today, was postponed at the sick visit until he has been back to his usual activity for two weeks. **S**

| Element | Detail |
|---|---|
| Home readings | Seven-day average 134/84 mmHg |
| Influenza | Recovering; dry morning cough; tires earlier |
| Amlodipine | No side effects |
| Echocardiogram | Ejection fraction 62%; mild concentric remodeling |
| Urine albumin-to-creatinine ratio | 12 mg/g |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tires earlier than usual since influenza |
| Respiratory | Positive | Dry cough on cold mornings; no breathlessness or sputum |
| Cardiovascular | Negative | No chest pain, palpitations or ankle swelling |
| Neurological | Negative | No dizziness |

4 systems reviewed. **S**

## Current medications

- Amlodipine 5 mg oral tablet once daily **S**
- Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once daily, continued through the polar winters **S**

## Allergies

- No known allergy **S**

## Objective

BP 136/84 mmHg; pulse 80 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 89 kg; BMI 30.8 kg/m². All vital signs are synthetic.

Urine albumin-to-creatinine ratio: 12 mg/g; Left ventricular ejection fraction (echocardiogram): 62%. All results are synthetic.

## Physical examination

| System | Finding |
|---|---|
| General | Well; afebrile; blood pressure 136/84, pulse 80; weight 89.0 kg, BMI 30.8 |
| Respiratory | Clear to auscultation |
| Cardiovascular | Regular rhythm; no murmur; no edema |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Essential hypertension on amlodipine** (I10). Home average down from 144/90 to 134/84, not yet below 130/80. Weight is falling and he has just been ill, so the dose is kept and blood pressure is rechecked at the preventive visit in two weeks; if it is still above goal at eight weeks, amlodipine will go to 10 mg. Echocardiogram shows a normal ejection fraction and mild concentric remodeling without hypertrophy; urine albumin normal. **S**
   - Continue amlodipine 5 mg.
   - Home readings weekly.
2. **Influenza A** (J10.1). Recovered, with a post-viral cough that is fading; lungs clear. **S**
   - No antibiotic; return if the cough worsens or he becomes breathless.
3. **Expedition preparation** (Z71.84). The exercise treadmill test should wait until two weeks of usual activity after the influenza. **S**
   - Exercise test at the eight-week review.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure (seated, five minutes' rest, large cuff, average of two readings) | Every visit | Completed today | 136/84 mmHg |
| Self-management | Home blood pressure monitoring | At diagnosis and two to four weeks after each treatment change, then weekly | Completed today | Average 134/84 mmHg four weeks after starting amlodipine |
| Examination | Weight, BMI and waist | Every visit | Completed today | 89.0 kg, BMI 30.8 |
| Examination | Cardiac auscultation | Every visit | Completed today | No murmur or gallop |
| Laboratory | Urine albumin-to-creatinine ratio | At diagnosis, then yearly | Completed today | 12 mg/g, normal; the sample deferred from intake |
| Laboratory | Basic metabolic panel, potassium and eGFR | Yearly (every six months only on a diuretic or renin-angiotensin blocker) | Up to date | Not needed for amlodipine; yearly |
| Imaging | Echocardiogram | At diagnosis of stage 2 hypertension or suspected left ventricular hypertrophy | Completed today | Ejection fraction 62%; mild concentric remodeling, septum 11 mm; normal valves |
| Medication safety | Amlodipine safety: ankle swelling, dizziness, flushing | At each visit | Completed today | No ankle swelling, dizziness or flushing |
| Examination | Exercise treadmill test before strenuous remote work | Before clearance | Due | Postponed at the sick visit until two weeks of usual activity after influenza; rebooked for the eight-week review |
| Referral | Wilderness and expedition medicine consultation | Before clearance for remote duty | Up to date | Seen four weeks ago |

## Goal progress

- Confirm or exclude hypertension with a week of home readings. Outcome by 1845-01-27: Home average 144/90 mmHg: stage 2 hypertension confirmed. **S**
- Blood pressure below 130/80 mmHg at home before departure. In progress; target 1845-04-07. **S**
- Lose about 5 percent of body weight before sailing by his own plan of walking, hill work and smaller portions. In progress; target 1845-05-05. **S**
- Medical clearance for the command with a written expedition health plan, medical kit and evacuation plan. In progress; target 1845-05-05. **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (Circulation 2025;152(11):e114-e218)
- CMID: Clinical Monitoring Intelligence Database, hypertension and hyperlipidemia monographs (2026), Aether Forge
- Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions (2018), U.S. Preventive Services Task Force
- Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza (2018), Infectious Diseases Society of America (Clin Infect Dis 2019;68(6):e1-e47)

## Follow-up

- Preventive visit with vaccinations in two weeks. Eight-week review with the exercise treadmill test. Call for breathlessness or a worsening cough. **S**
- Next scheduled visit 1845-03-10: periodic adult preventive visit. **S**
